StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
121
This year
7
Publishing Date
2023 - 11 - 01
2
2023 - 03 - 30
2
2023 - 02 - 28
2
2022 - 04 - 06
1
2022 - 03 - 17
1
2022 - 02 - 16
2
2022 - 01 - 19
1
2022 - 01 - 04
1
2021 - 11 - 17
1
2021 - 11 - 10
1
2021 - 11 - 03
1
2021 - 10 - 28
1
2021 - 10 - 12
1
2021 - 10 - 01
1
2021 - 09 - 30
1
2021 - 09 - 16
1
2021 - 09 - 07
1
2021 - 08 - 31
1
2021 - 08 - 05
1
2021 - 07 - 30
1
2021 - 07 - 29
1
2021 - 07 - 07
1
2021 - 07 - 05
1
2021 - 07 - 02
1
2021 - 06 - 30
1
2021 - 06 - 15
1
2021 - 05 - 28
1
2021 - 05 - 17
1
2021 - 05 - 13
1
2021 - 05 - 06
1
2021 - 04 - 30
1
2021 - 04 - 29
1
2021 - 03 - 31
1
2021 - 03 - 11
1
2021 - 03 - 03
1
2021 - 02 - 25
1
2021 - 02 - 05
1
2021 - 01 - 29
1
2021 - 01 - 21
1
2020 - 12 - 17
1
2020 - 12 - 16
1
2020 - 12 - 10
1
2020 - 12 - 02
1
2020 - 11 - 30
2
2020 - 11 - 05
1
2020 - 11 - 03
1
2020 - 10 - 29
1
2020 - 10 - 16
1
2020 - 09 - 30
1
2020 - 09 - 24
1
2020 - 09 - 15
1
2020 - 09 - 11
1
2020 - 09 - 09
1
2020 - 09 - 08
1
2020 - 08 - 31
1
2020 - 08 - 06
1
2020 - 07 - 31
1
2020 - 07 - 29
1
2020 - 06 - 30
1
2020 - 06 - 01
2
Sector
Health technology
121
Professional, scientific, and technical services
1
Tags
Agreement
4
Alliances
1
Application
2
Biotech
1
Brexafemme
1
Business
10
Calendar of events
6
Clearance
1
Clinical trials
1
Clinical-trials-phase-ii
1
Company announcement
7
Conference
13
Day
1
Deadline
5
Disease
4
Drug
3
Earnings releases and operating results
2
Fda
4
Fda acceptance
1
Financial
7
Financial results
5
First
1
Food
1
Fungal infection
1
Genetown
2
Global
2
Grant
14
Granted
14
Grants
11
Health
3
Infection
2
Infections
6
Infectious disease
1
Injection
3
Iot
1
License
4
Life
1
Medical
1
N/a
92
Nasdaq
20
Offering
2
People
3
Phase 1
2
Phase 2
2
Phase 2b
2
Phase 3
3
Positive
3
Presentation
5
Program
3
Report
9
Results
28
Spr206
3
Spr720
2
Therapeutics
70
Topline
3
Topline results
2
Treatment
3
Trial
8
Update
15
Year
5
Entities
Arvinas, inc.
1
Glaxosmithkline plc
4
Invivo therapeutics holdings corp.
1
Pfizer, inc.
4
Ptc therapeutics, inc.
1
Sanofi
2
Scynexis, inc.
1
Spero therapeutics, inc.
121
Theravance biopharma, inc.
1
Tscan therapeutics inc
1
Symbols
ABBV
156
ABEO
115
ADCT
145
AKBA
116
ALDX
123
ALLO
177
AMGN
137
AMRN
134
AQST
147
ATHE
106
AXSM
116
AZN
117
BCLI
131
BMY
131
BTAI
167
CALT
141
FATE
255
FULC
134
GILD
107
GOOG
193
GOOGL
193
GSK
150
GTHX
136
HOTH
109
HZNP
146
JNJ
521
KPTI
166
LCTX
109
LLY
283
MCRB
116
MDNA
108
MOR
186
MPSYF
182
MS
208
NKTR
366
NRIX
147
NTLA
112
NVS
225
NVSEF
191
OCX
178
ONTX
113
OTLK
146
PSTV
123
PSTX
110
PTCT
266
RLFTF
109
RLFTY
109
SNY
705
SNYNF
547
SPRO
121
SRNE
229
SRPT
164
TGTX
148
TVTX
120
TXMD
190
UTHR
142
VTGN
116
VXRT
181
VYNE
172
YMAB
178
Exchanges
Nasdaq
121
Nyse
7
Crawled Date
2023 - 11 - 01
2
2023 - 05 - 01
5
2023 - 03 - 30
2
2023 - 02 - 28
2
2022 - 09 - 07
1
2022 - 09 - 06
1
2022 - 08 - 09
1
2022 - 07 - 21
1
2022 - 07 - 19
1
2022 - 07 - 12
1
2022 - 06 - 28
1
2022 - 06 - 21
1
2022 - 06 - 17
1
2022 - 06 - 15
1
2022 - 06 - 14
1
2022 - 05 - 11
1
2022 - 05 - 09
1
2022 - 05 - 03
1
2022 - 04 - 21
1
2022 - 04 - 06
1
2022 - 03 - 17
1
2022 - 02 - 16
2
2022 - 01 - 19
1
2022 - 01 - 04
1
2021 - 11 - 17
1
2021 - 11 - 10
1
2021 - 11 - 03
1
2021 - 10 - 28
1
2021 - 10 - 12
1
2021 - 10 - 01
1
2021 - 09 - 30
1
2021 - 09 - 16
1
2021 - 09 - 07
1
2021 - 08 - 31
1
2021 - 08 - 05
1
2021 - 07 - 30
1
2021 - 07 - 29
1
2021 - 07 - 07
1
2021 - 07 - 05
1
2021 - 07 - 02
1
2021 - 06 - 30
1
2021 - 06 - 15
1
2021 - 05 - 28
1
2021 - 05 - 17
1
2021 - 05 - 13
1
2021 - 05 - 06
1
2021 - 04 - 30
1
2021 - 04 - 29
1
2021 - 04 - 01
1
2021 - 03 - 11
1
2021 - 03 - 03
1
2021 - 02 - 25
1
2021 - 02 - 05
1
2021 - 01 - 29
1
2021 - 01 - 21
1
2020 - 12 - 17
1
2020 - 12 - 16
1
2020 - 12 - 10
1
2020 - 12 - 04
19
2020 - 12 - 02
1
Crawled Time
00:00
1
07:00
1
10:00
5
11:00
1
12:00
8
12:07
19
12:15
4
12:20
11
12:30
1
13:00
9
13:01
2
13:03
2
13:15
1
13:20
3
13:30
1
14:00
3
14:01
1
14:03
1
14:20
5
14:30
1
15:00
1
15:20
2
16:00
1
18:00
1
19:00
2
20:00
14
21:00
11
22:00
7
23:00
2
Source
www.biospace.com
10
www.globenewswire.com
102
www.prnewswire.com
9
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
therapeutics
symbols :
Spro
save search
Spero Therapeutics Announces Fourth Quarter and Full Year 2023 Operating Results and Provides a Business Update
Published:
2024-03-13
(Crawled : 20:00)
- globenewswire.com
SPRO
|
$1.41
-4.08%
-4.26%
380K
|
Health Technology
|
-9.64%
|
O:
10.24%
H:
3.28%
C:
-4.92%
business
year
update
therapeutics
results
Spero Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, March 13, 2024
Published:
2024-03-06
(Crawled : 13:00)
- globenewswire.com
SPRO
|
$1.41
-4.08%
-4.26%
380K
|
Health Technology
|
-10.18%
|
O:
-0.6%
H:
4.22%
C:
3.61%
report
business
year
update
therapeutics
financial
results
Spero Therapeutics Announces Clearance of IND for SPR206 to Treat MDR Gram-negative Bacterial Infections
Published:
2024-02-28
(Crawled : 13:00)
- globenewswire.com
SPRO
|
$1.41
-4.08%
-4.26%
380K
|
Health Technology
|
-8.54%
|
O:
0.0%
H:
4.27%
C:
1.22%
spr206
treat
clearance
infections
therapeutics
Spero Therapeutics to Present at Cowen’s 44th Annual Healthcare Conference
Published:
2024-02-26
(Crawled : 13:00)
- globenewswire.com
SPRO
|
$1.41
-4.08%
-4.26%
380K
|
Health Technology
|
-0.66%
|
O:
-1.32%
H:
5.37%
C:
0.67%
conference
therapeutics
Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published:
2024-01-31
(Crawled : 21:00)
- globenewswire.com
SPRO
|
$1.41
-4.08%
-4.26%
380K
|
Health Technology
|
-1.32%
|
O:
0.66%
H:
3.27%
C:
2.61%
nasdaq
grants
therapeutics
Spero Therapeutics Provides Corporate Update and 2024 Outlook
Published:
2024-01-05
(Crawled : 13:00)
- globenewswire.com
SPRO
|
$1.41
-4.08%
-4.26%
380K
|
Health Technology
|
2.04%
|
O:
0.0%
H:
2.04%
C:
-2.72%
update
therapeutics
Spero Therapeutics Announces First Patient, First Visit for Phase 3 PIVOT-PO Trial Evaluating Tebipenem HBr in Complicated Urinary Tract Infections
Published:
2024-01-02
(Crawled : 13:00)
- globenewswire.com
SPRO
|
$1.41
-4.08%
-4.26%
380K
|
Health Technology
|
2.04%
|
O:
0.0%
H:
5.44%
C:
3.4%
first
infections
therapeutics
Spero Therapeutics Announces Third Quarter 2023 Operating Results and Provides a Business Update
Published:
2023-11-13
(Crawled : 21:00)
- globenewswire.com
SPRO
|
$1.41
-4.08%
-4.26%
380K
|
Health Technology
|
35.14%
|
O:
2.7%
H:
7.89%
C:
-4.39%
business
update
therapeutics
results
Spero Therapeutics to Provide Business Update and Report Third Quarter 2023 Financial Results on Monday, November 13, 2023
Published:
2023-11-06
(Crawled : 13:00)
- globenewswire.com
SPRO
|
$1.41
-4.08%
-4.26%
380K
|
Health Technology
|
26.05%
|
O:
0.84%
H:
1.67%
C:
-3.33%
report
business
update
therapeutics
financial
results
Spero Therapeutics to Present at Upcoming November Investor Conferences
Published:
2023-11-01
(Crawled : 20:00)
- globenewswire.com
SPRO
|
$1.41
-4.08%
-4.26%
380K
|
Health Technology
|
31.58%
|
O:
0.88%
H:
0.87%
C:
-0.87%
therapeutics
Spero Therapeutics Appoints Esther Rajavelu as Chief Financial Officer and Chief Business Officer
Published:
2023-11-01
(Crawled : 12:00)
- globenewswire.com
SPRO
|
$1.41
-4.08%
-4.26%
380K
|
Health Technology
|
38.89%
|
O:
2.78%
H:
3.6%
C:
2.7%
business
therapeutics
financial
Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published:
2023-10-31
(Crawled : 20:00)
- globenewswire.com
SPRO
|
$1.41
-4.08%
-4.26%
380K
|
Health Technology
|
38.89%
|
O:
2.78%
H:
3.6%
C:
2.7%
nasdaq
grants
therapeutics
Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published:
2023-09-29
(Crawled : 20:00)
- globenewswire.com
SPRO
|
$1.41
-4.08%
-4.26%
380K
|
Health Technology
|
Email alert
Add to watchlist
nasdaq
grants
therapeutics
Spero Therapeutics to Present at Cantor’s Global Healthcare 2023 Investor Conference
Published:
2023-09-20
(Crawled : 20:00)
- globenewswire.com
SPRO
|
$1.41
-4.08%
-4.26%
380K
|
Health Technology
|
21.95%
|
O:
0.81%
H:
0.0%
C:
-1.61%
conference
global
therapeutics
Sensorium Therapeutics Appoints Veteran Life Sciences Executive Mr. David Southwell to its Board of Directors
Published:
2023-09-12
(Crawled : 14:30)
- biospace.com/
TCRX
|
News
0 d
|
$6.79
-1.88%
-1.91%
280K
|
Professional, Scientific, and T...
|
159.62%
|
O:
-1.92%
H:
7.06%
C:
2.75%
SPRO
|
$1.41
-4.08%
-4.26%
380K
|
Health Technology
|
12.78%
|
O:
0.0%
H:
0.0%
C:
-2.26%
PTCT
|
News
S
|
$25.32
2.55%
2.49%
3.9M
|
Health Technology
|
-37.4%
|
O:
-0.47%
H:
1.2%
C:
0.95%
life
sciences
therapeutics
Spero Therapeutics to Present at H.C. Wainwright 25th Annual Global Investment Conference
Published:
2023-09-06
(Crawled : 12:00)
- globenewswire.com
SPRO
|
$1.41
-4.08%
-4.26%
380K
|
Health Technology
|
4.9%
|
O:
0.7%
H:
1.02%
C:
-4.17%
conference
global
therapeutics
Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published:
2023-08-31
(Crawled : 20:00)
- globenewswire.com
SPRO
|
$1.41
-4.08%
-4.26%
380K
|
Health Technology
|
0.0%
|
O:
0.67%
H:
2.65%
C:
0.66%
nasdaq
grants
therapeutics
Spero Therapeutics Announces Second Quarter 2023 Operating Results and Provides a Business Update
Published:
2023-08-10
(Crawled : 20:00)
- globenewswire.com
SPRO
|
$1.41
-4.08%
-4.26%
380K
|
Health Technology
|
3.45%
|
O:
1.38%
H:
0.68%
C:
-4.76%
business
update
therapeutics
results
Spero Therapeutics to Provide Business Update and Report Second Quarter 2023 Financial Results on Thursday, August 10, 2023
Published:
2023-08-03
(Crawled : 12:00)
- globenewswire.com
SPRO
|
$1.41
-4.08%
-4.26%
380K
|
Health Technology
|
-2.28%
|
O:
2.28%
H:
0.0%
C:
-3.82%
report
business
update
therapeutics
financial
results
Spero Therapeutics Announces Special Protocol Assessment Agreement with FDA for Phase 3 PIVOT-PO Trial of Tebipenem HBr
Published:
2023-07-31
(Crawled : 12:00)
- globenewswire.com
SPRO
|
$1.41
-4.08%
-4.26%
380K
|
Health Technology
|
5.63%
|
O:
9.15%
H:
6.45%
C:
5.16%
fda
trial
therapeutics
agreement
← Previous
1
2
3
4
5
6
7
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.